Replies to post #9387 on OncoSec Medical Inc (ONCSQ)

[gemmill]

A Q for anyone who knows the A...
In Z's conversation with Punit, he mentioned that other companies would have to go through ONCS if they wanted to use IL-12 with Electroporation. This is awesome for us of course, but I'm just curious about something. With this talk (Speculative talk) of IL-xx being used in another trial, would they be limited to selection of what they could use, based off of other companies having different patents?
For example... I read Inovio are going to be using a IL-xx, if ONCS decides to pursue a combination trial with an Anti-PD1, and the same IL-xx Inovio is using. How would patents work in that regard? Whoever files first? But, then what happens to the other company pursuing a clinical trial?